Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Promontory Therapeutics

Request full access

Clinical-stage company developing novel small molecule immunogenic anti-cancer agents with a focus on oncology therapeutics

New York City, United StatesFounded 2010Biotech & Life Sciences

About Promontory Therapeutics

Promontory Therapeutics is a private, clinical-stage drug development company specializing in oncology therapeutics. The company is dedicated to advancing novel small molecule immunogenic anti-cancer agents. Its lead drug candidate, PT 112, is a highly potent immunogenic cell death (ICD) inducer currently in Phase 2 clinical development. PT 112 has demonstrated single-agent activity and safety, and it shows synergy with immune checkpoint inhibitors. Promontory Therapeutics operates multiple clinical trials across the United States and Europe, aiming to lead the development of immunogenic small molecules in cancer care. The company collaborates with outstanding institutions and partners to further its mission. Promontory Therapeutics generates revenue through partnerships, licensing agreements, and potential future sales of its drug candidates.

Source: Dealroom company data

Promontory Therapeutics in the New York City ecosystem

Live from Dealroom

The Promontory Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Adinvest AG
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Promontory Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Promontory Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.